Palvella Therapeutics (PVLA) FCF Margin Growth (5y) (2019 - 2024)
Palvella Therapeutics (PVLA) FCF Margin Growth (5y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -190,102.00 |
| Dec 31, 2023 | 87,312.00 |
| Sep 30, 2023 | 12,580.00 |
| Jun 30, 2023 | 1,294.00 |
| Mar 31, 2023 | -129,427.00 |
| Dec 31, 2022 | -1.01 Mn |
| Sep 30, 2022 | -390,874.00 |
| Jun 30, 2022 | -665,877.00 |
| Mar 31, 2022 | -211,519.00 |
| Dec 31, 2021 | 12,184.00 |
| Sep 30, 2021 | 11,506.00 |
| Jun 30, 2021 | 455,827.00 |
| Mar 31, 2021 | -25,070.00 |
| Dec 31, 2020 | 52,881.00 |
| Sep 30, 2020 | 63,906.00 |
| Jun 30, 2020 | 184,599.00 |
| Mar 31, 2020 | 154,112.00 |
| Sep 30, 2019 | 15,888.00 |
| Jun 30, 2019 | -5,405.00 |